Martín, Miguel <br/><br/>
Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2015 
 - 3788-95 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2015.61.9510  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Capecitabine--administration & dosage<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Docetaxel<br/>Drug Administration Schedule<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Follow-Up Studies<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis<br/>Middle Aged<br/>Neoplasm Staging<br/>Odds Ratio<br/>Taxoids--administration & dosage<br/>Treatment Outcome